MARKET

ELTX

ELTX

Elicio Therapeutics, Inc.
NASDAQ
5.52
+0.03
+0.55%
After Hours: 5.44 -0.08 -1.45% 19:02 05/12 EDT
OPEN
5.59
PREV CLOSE
5.49
HIGH
5.65
LOW
5.42
VOLUME
6.77K
TURNOVER
--
52 WEEK HIGH
11.45
52 WEEK LOW
3.342
MARKET CAP
88.06M
P/E (TTM)
-1.2979
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ELTX last week (0505-0509)?
Weekly Report · 17h ago
Weekly Report: what happened at ELTX last week (0428-0502)?
Weekly Report · 05/05 10:05
Here's Why Elicio Therapeutics (ELTX) Could be Great Choice for a Bottom Fisher
NASDAQ · 05/01 13:55
Weekly Report: what happened at ELTX last week (0421-0425)?
Weekly Report · 04/28 10:09
Weekly Report: what happened at ELTX last week (0414-0418)?
Weekly Report · 04/21 10:09
Elicio Therapeutics grants inducement award to new chief strategy and financial officer
Seeking Alpha · 04/16 20:11
Press Release: Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires
Dow Jones · 04/16 20:05
Seven new option listings and one option delisting on April 16th
TipRanks · 04/16 12:30
More
About ELTX
More
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a pipeline of immunotherapies for the treatment of cancer. The Company provides a platform, amphiphile (AMP) that delivers immunotherapeutics directly to the lymph nodes (brain center) of the immune system. The Company’s clinical and preclinical pipeline includes the lymph node targeted therapeutic cancer vaccines ELI-002, which is being evaluated in a Phase II study, designed to stimulate an immune response against mutant kirsten rat sarcoma (KRAS). Its ELI-007 is being evaluated in a preclinical study for the treatment of mutant v-raf murine sarcoma viral oncogene homolog B1 (BRAF) driven cancers, and ELI-008, is being evaluated in a preclinical study for use in the treatment of mutated tumor protein p53 (TP53) expressing cancers.
Recently
Symbol
Price
%Change

Webull offers Angion Biomedica Corp stock information, including NASDAQ: ELTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELTX stock methods without spending real money on the virtual paper trading platform.